english.prescrire.org > Prescrire International > N°23 - June 1996

n°23

June 1996

Issue Contents
Editorial

Guiding principles

p.96

Marketing Authorisations


Buprenorphine tablets

p.66-70

Alglucerase solution for IV injection

p.71-72

Atovaquone tablets

p.73-76

Pneumocystis carinii pneumonia in AIDS

p.75

Simvastatin tablets in secondary prevention

p.76-77

Pravastatin tablets in secondary prevention

p.78-79

Ursodeoxycholic acid capsules and tablets

p.80-82

Acyclovir tablets and oral suspension

p.82-83

Adverse Effects


17th French pharmacovigilance meeting: clozapine and agranulocytosis: results of a cohort study

p.84

17th French pharmacovigilance meeting: acute renal failure due to intravenous immunoglobulin

p.84

17th French pharmacovigilance meeting: acute drug-induced agranulocytosis

p.84-85

17th French pharmacovigilance meeting: drug-induced aseptic meningitis

p.85

17th French pharmacovigilance meeting: convulsions on fluoxetine

p.85

17th French pharmacovigilance meeting: bleeding on fluoxetine and paroxetine

p.85

17th French pharmacovigilance meeting: cryodysaesthesia due to sparfloxacin?

p.85

17th French pharmacovigilance meeting: neuropsychiatric effects of fluoroquinolones

p.85

17th French pharmacovigilance meeting: drug-induced galactorrhoea

p.85

17th French pharmacovigilance meeting: spontaneous or encouraged notifications

p.85-86

17th French pharmacovigilance meeting: hyponatraemia on paroxetine

p.86

Is oral naftidrofuryl hepatotoxic?

p.86

Reviews


Calcium antagonists: overused and inadequately assessed

p.87-91

Sodium hypochlorite against HIV

p.92-93

Primary prevention of coronary artery disease: promising pravastatin?

p.93-94

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe